SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-223230
Filing Date
2024-09-23
Accepted
2024-09-23 06:12:30
Documents
13
Period of Report
2024-09-23
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d884691d8k.htm   iXBRL 8-K 30573
  Complete submission text file 0001193125-24-223230.txt   154169

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA idya-20240923.xsd EX-101.SCH 2515
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE idya-20240923_lab.xml EX-101.LAB 17957
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE idya-20240923_pre.xml EX-101.PRE 11241
15 EXTRACTED XBRL INSTANCE DOCUMENT d884691d8k_htm.xml XML 3737
Mailing Address 5000 SHORELINE CT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 5000 SHORELINE CT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-443-6209
IDEAYA Biosciences, Inc. (Filer) CIK: 0001676725 (see all company filings)

IRS No.: 474268251 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38915 | Film No.: 241314564
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)